National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.
Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.
An immunotherapy for some patients with advanced skin cancer and a targeted drug for some women with breast cancer have been approved for NHS Scotland.
Transgender women undergoing hormone treatment have an increased risk of breast cancer compared to cisgender men, new research suggests.